X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (43) 43
index medicus (38) 38
oncology (32) 32
male (31) 31
middle aged (28) 28
adult (27) 27
hematology (26) 26
female (23) 23
aged (18) 18
chemotherapy (18) 18
antineoplastic combined chemotherapy protocols - therapeutic use (13) 13
cancer (13) 13
prognosis (13) 13
prospective studies (12) 12
treatment outcome (12) 12
active antiretroviral therapy (11) 11
stem-cell transplantation (10) 10
adolescent (9) 9
hiv (9) 9
medicine & public health (9) 9
risk factors (9) 9
young adult (9) 9
aids-related lymphoma (8) 8
combined modality therapy (8) 8
stem cells (8) 8
aids (7) 7
b-cell lymphoma (7) 7
care and treatment (7) 7
lymphoma (7) 7
risk (7) 7
survival (7) 7
transplantation (7) 7
antineoplastic combined chemotherapy protocols - adverse effects (6) 6
cohort studies (6) 6
etoposide (6) 6
germany - epidemiology (6) 6
hiv infections - complications (6) 6
lymphoma, aids-related - drug therapy (6) 6
neoplasm staging (6) 6
non-hodgkin-lymphoma (6) 6
non-hodgkins-lymphoma (6) 6
retrospective studies (6) 6
rituximab (6) 6
survival analysis (6) 6
testicular cancer (6) 6
tumors (6) 6
antineoplastic combined chemotherapy protocols - administration & dosage (5) 5
bone-marrow-transplantation (5) 5
cisplatin (5) 5
cyclophosphamide - administration & dosage (5) 5
germany (5) 5
hiv infections - drug therapy (5) 5
immunology (5) 5
infectious diseases (5) 5
intensive chemotherapy (5) 5
lymphomas (5) 5
metastasis (5) 5
multivariate analysis (5) 5
randomized-trial (5) 5
remission induction (5) 5
research (5) 5
stem cell transplantation (5) 5
survival rate (5) 5
transplantation, autologous (5) 5
vincristine (5) 5
vincristine - administration & dosage (5) 5
analysis (4) 4
antineoplastic agents - administration & dosage (4) 4
antineoplastic agents - therapeutic use (4) 4
antiretroviral therapy, highly active (4) 4
autologous transplantation (4) 4
blood (4) 4
disease (4) 4
disease-free survival (4) 4
dose-response relationship, drug (4) 4
etoposide - administration & dosage (4) 4
human-immunodeficiency-virus (4) 4
immunodeficiency (4) 4
medical oncology (4) 4
medical oncology - standards (4) 4
neutropenia (4) 4
patient outcomes (4) 4
practice guidelines as topic (4) 4
testicular neoplasms - pathology (4) 4
therapy (4) 4
acquired immunodeficiency syndrome - drug therapy (3) 3
aged, 80 and over (3) 3
aids/hiv (3) 3
anti-retroviral agents - administration & dosage (3) 3
antimitotic agents (3) 3
antineoplastic agents (3) 3
antiretroviral therapy (3) 3
autografts (3) 3
bone-marrow (3) 3
cancer research (3) 3
carboplatin (3) 3
cd4 lymphocyte count (3) 3
cisplatin - administration & dosage (3) 3
classification (3) 3
complications (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Karger Kompass Onkologie, ISSN 2296-5416, 03/2019, Volume 6, Issue 1, pp. 6 - 8
Journal Article
Karger Kompass Onkologie, ISSN 2296-5416, 2019, Volume 6, Issue 1, pp. 6 - 8
Journal Article
Journal Article
2016, 1st ed. 2016., ISBN 9783319268552
This book presents a general introduction to and review of HIV-associated hematological malignancies, with a special focus on practical management issues. Each... 
Medicine | Hematology | Oncology
Web Resource
2016, 1st ed. 2016, ISBN 9783319268552, 239
This book presents a general introduction to and review of HIV-associated hematological malignancies, with a special focus on practical management issues. Each... 
Clinical & internal medicine | Viral carcinogenesis | Oncology | Medicine & Public Health | Hematology | HIV infections | Blood
eBook
Journal Article
Journal Article
PLoS Computational Biology, ISSN 1553-734X, 05/2012, Volume 8, Issue 5, p. e1002511
Journal Article
Journal of Cancer Research and Clinical Oncology, ISSN 0171-5216, 03/2019, Volume 145, Issue 3, pp. 717 - 723
Background Treatment options for patients (pts) with multiply relapsed or refractory metastatic germ cell cancer (GCC) are limited. The mTOR inhibitor... 
Refractory | mTOR | Cisplatin resistance | Everolimus | Testicular cancer | Germ cell cancer | ONCOLOGY | FAILURE | Care and treatment | Relapse | Oncology, Experimental | Dosage and administration | Metastasis | Angiogenesis inhibitors | Research | Drug therapy, Combination | Cancer | Diseases | Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2012, Volume 30, Issue 33, pp. 4117 - 4123
Purpose Although the outcome of patients with HIV-related Hodgkin lymphoma (HIV-HL) has markedly improved since the introduction of combined antiretroviral... 
PROGNOSTIC-FACTORS | ONCOLOGY | INFECTION HD-HIV | ACTIVE ANTIRETROVIRAL THERAPY | DISEASE | RANDOMIZED-TRIAL | STANFORD-V | STEM-CELL TRANSPLANTATION | PATIENTS PTS | IMMUNODEFICIENCY | CHEMOTHERAPY | Procarbazine - administration & dosage | Cyclophosphamide - administration & dosage | Dacarbazine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Prospective Studies | Hodgkin Disease - pathology | Humans | Lymphoma, AIDS-Related - pathology | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Vinblastine - administration & dosage | Cyclophosphamide - adverse effects | Young Adult | Hodgkin Disease - radiotherapy | Vinblastine - adverse effects | Hodgkin Disease - drug therapy | Vincristine - administration & dosage | Adult | Female | Doxorubicin - administration & dosage | Lymphoma, AIDS-Related - drug therapy | Dacarbazine - administration & dosage | Prednisone - administration & dosage | Etoposide - adverse effects | Prednisone - adverse effects | Etoposide - administration & dosage | Treatment Outcome | Combined Modality Therapy | Bleomycin - administration & dosage | Bleomycin - adverse effects | Remission Induction | Disease-Free Survival | Procarbazine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | HIV Infections - complications | Lymphoma, AIDS-Related - radiotherapy | Vincristine - adverse effects | Aged | Neoplasm Staging | Doxorubicin - adverse effects
Journal Article
Journal Article
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 1719 - 1719
Abstract Introduction: Human immunodeficiency virus (HIV)-associated primary effusion lymphoma (PEL) is a rare and aggressive subtype of B-cell Non-Hodgkin... 
Journal Article
Transfusion, ISSN 0041-1132, 10/2016, Volume 56, Issue 10, pp. 2615 - 2617
BACKGROUND Autologous peripheral blood stem cells (PBSCs) are usually cryopreserved before high‐dose chemotherapy (HDCT) and autologous peripheral blood stem... 
NUMBER | GRANULOCYTES | LYMPHOMA | INFUSION | DIMETHYL-SULFOXIDE | HEMATOLOGY | 5-PERCENT | BLOOD | TRANSPLANTATION | Myeloablative Agonists - therapeutic use | Lymphoma, Follicular - therapy | Aphasia, Broca - chemically induced |